Cart
sales@molnova.com
NorA-IN-1
CAS No. 1389310-69-3
NorA-IN-1( —— )
Catalog No. M37304 CAS No. 1389310-69-3
NorA-IN-1 is a NorA efflux inhibitor, which can be used to study overcoming multidrug resistance based on microbial efflux transporter proteins.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 79 | Get Quote |
|
| 5MG | 170 | Get Quote |
|
| 10MG | 275 | Get Quote |
|
| 25MG | 450 | Get Quote |
|
| 50MG | 642 | Get Quote |
|
| 100MG | 871 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNorA-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionNorA-IN-1 is a NorA efflux inhibitor, which can be used to study overcoming multidrug resistance based on microbial efflux transporter proteins.
-
DescriptionNorA-IN-1 (Compound 16) is a NorA inhibitor. NorA-IN-1 inhibits NorA efflux pump in everted membrane vesicles. NorA-IN-1 can be used for research of multidrug resistance.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1389310-69-3
-
Formula Weight314.33
-
Molecular FormulaC18H18O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C=CC=1C(OC)=CC(OC)=CC1OC)C2=CC=C(O)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Holler JG, et al. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles. Bioorg Med Chem. 2012 Jul 15;20(14):4514-21.?
molnova catalog
related products
-
2-Methoxypyrazine
2-Methoxypyrazine is a natural product.
-
(±)5(6)-EpETE methyl...
(±)5(6)-EpETE methyl ester is a derivative of 5(6)-EpETE which is stable enough to ship and handle routinely.(±) 5(6)-EpETE methyl ester is a chemically less reactive derivative of 5(6)-EpETE.
-
Protein Kinase C Pep...
Protein Kinase C Peptide Substrate targets specific cell spacers ina manner that is dependent on second messengers and specific adaptor proteins in response to extracellular signals that activate g protein-coupled receptors, tyrosine Kinase receptors, or tyrosine kinase-coupled receptors.
